|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 20 3519-3527, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
T Ebisawa, K Tada, I Kitajima, K Tojo, TK Sampath, M Kawabata, K Miyazono and T Imamura
Department of Biochemistry, The Cancer Institute of JFCR, and Research for the Future Program, Japan Society for the Promotion of Science, Toshima-ku, Tokyo 170-8455, Japan.
Bone morphogenetic protein (BMP)-6 is a member of the transforming growth factor (TGF)-(&bgr;) superfamily, and is most similar to BMP-5, osteogenic protein (OP)-1/BMP-7, and OP-2/BMP-8. In the present study, we characterized the endogenous BMP-6 signaling pathway during osteoblast differentiation. BMP-6 strongly induced alkaline phosphatase (ALP) activity in cells of osteoblast lineage, including C2C12 cells, MC3T3-E1 cells, and ROB-C26 cells. The profile of binding of BMP-6 to type I and type II receptors was similar to that of OP-1/BMP-7 in C2C12 cells and MC3T3-E1 cells; BMP-6 strongly bound to activin receptor-like kinase (ALK)-2 (also termed ActR-I), together with type II receptors, i.e. BMP type II receptor (BMPR-II) and activin type II receptor (ActR-II). In addition, BMP-6 weakly bound to BMPR-IA (ALK-3), to which BMP-2 also bound. In contrast, binding of BMP-6 to BMPR-IB (ALK-6), and less efficiently to ALK-2 and BMPR-IA, together with BMPR-II was detected in ROB-C26 cells. Intracellular signalling was further studied using C2C12 and MC3T3-E1 cells. Among the receptor-regulated Smads activated by BMP receptors, BMP-6 strongly induced phosphorylation and nuclear accumulation of Smad5, and less efficiently those of Smad1. However, Smad8 was constitutively phosphorylated, and no further phosphorylation or nuclear accumulation of Smad8 by BMP-6 was observed. These findings indicate that in the process of differentiation to osteoblasts, BMP-6 binds to ALK-2 as well as other type I receptors, and transduces signals mainly through Smad5 and possibly through Smad1.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  P. D. Upton, R. J. Davies, R. C. Trembath, and N. W. Morrell Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells J. Biol. Chem., June 5, 2009; 284(23): 15794 - 15804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Inagaki, F. Otsuka, T. Miyoshi, M. Yamashita, M. Takahashi, J. Goto, J. Suzuki, and H. Makino p38-Mitogen-Activated Protein Kinase Stimulated Steroidogenesis in Granulosa Cell-Oocyte Cocultures: Role of Bone Morphogenetic Proteins 2 and 4 Endocrinology, April 1, 2009; 150(4): 1921 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahata, Y. Inoue, H. Tsuda, I. Imoto, D. Koinuma, M. Hayashi, T. Ichikura, T. Yamori, K. Nagasaki, M. Yoshida, et al. SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-{beta} Signal in Gastric Cancer Cells J. Biol. Chem., January 30, 2009; 284(5): 3334 - 3344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Koinuma, S. Tsutsumi, N. Kamimura, H. Taniguchi, K. Miyazawa, M. Sunamura, T. Imamura, K. Miyazono, and H. Aburatani Chromatin Immunoprecipitation on Microarray Analysis of Smad2/3 Binding Sites Reveals Roles of ETS1 and TFAP2A in Transforming Growth Factor {beta} Signaling Mol. Cell. Biol., January 1, 2009; 29(1): 172 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fukunaga, Y. Inoue, S. Komiya, K. Horiguchi, K. Goto, M. Saitoh, K. Miyazawa, D. Koinuma, A. Hanyu, and T. Imamura Smurf2 Induces Ubiquitin-dependent Degradation of Smurf1 to Prevent Migration of Breast Cancer Cells J. Biol. Chem., December 19, 2008; 283(51): 35660 - 35667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, F. Otsuka, T. Miyoshi, H. Otani, J. Goto, M. Yamashita, T. Ogura, H. Makino, and H. Doihara Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation J. Endocrinol., December 1, 2008; 199(3): 445 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gamell, N. Osses, R. Bartrons, T. Ruckle, M. Camps, J. L. Rosa, and F. Ventura BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity J. Cell Sci., December 1, 2008; 121(23): 3960 - 3970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xia, J. L. Babitt, Y. Sidis, R. T. Chung, and H. Y. Lin Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin Blood, May 15, 2008; 111(10): 5195 - 5204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miyoshi, F. Otsuka, H. Otani, K. Inagaki, J. Goto, M. Yamashita, T. Ogura, Y. Iwasaki, and H. Makino Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells J. Endocrinol., April 1, 2008; 197(1): 159 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Nicol, M-O Faure, J R McNeilly, J Fontaine, C Taragnat, and A S McNeilly Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in L{beta}T2 gonadotrophs J. Endocrinol., March 1, 2008; 196(3): 497 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamashita, F. Otsuka, T. Mukai, H. Otani, K. Inagaki, T. Miyoshi, J. Goto, M. Yamamura, and H. Makino Simvastatin antagonizes tumor necrosis factor-{alpha} inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway J. Endocrinol., March 1, 2008; 196(3): 601 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kotzsch, J. Nickel, A. Seher, K. Heinecke, L. van Geersdaele, T. Herrmann, W. Sebald, and T. D. Mueller Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome J. Biol. Chem., February 29, 2008; 283(9): 5876 - 5887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Goto, Y. Kamiya, T. Imamura, K. Miyazono, and K. Miyazawa Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors J. Biol. Chem., July 13, 2007; 282(28): 20603 - 20611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Scherner, S. K. Meurer, L. Tihaa, A. M. Gressner, and R. Weiskirchen Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-beta1 and BMP-7 Signaling J. Biol. Chem., May 11, 2007; 282(19): 13934 - 13943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1513 - F1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miyoshi, F. Otsuka, K. Inagaki, H. Otani, M. Takeda, J. Suzuki, J. Goto, T. Ogura, and H. Makino Differential Regulation of Steroidogenesis by Bone Morphogenetic Proteins in Granulosa Cells: Involvement of Extracellularly Regulated Kinase Signaling and Oocyte Actions in Follicle-Stimulating Hormone-Induced Estrogen Production Endocrinology, January 1, 2007; 148(1): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nagata, K. Goto, S. Ehata, N. Kobayashi, M. Saitoh, H. Miyoshi, T. Imamura, K. Miyazawa, and K. Miyazono Nuclear and cytoplasmic c-Ski differently modulate cellular functions Genes Cells, November 1, 2006; 11(11): 1267 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bangi and K. Wharton Dual function of the Drosophila Alk1/Alk2 ortholog Saxophone shapes the Bmp activity gradient in the wing imaginal disc Development, September 1, 2006; 133(17): 3295 - 3303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mazerbourg and A. J.W. Hsueh Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands Hum. Reprod. Update, July 1, 2006; 12(4): 373 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Inagaki, F. Otsuka, J. Suzuki, Y. Kano, M. Takeda, T. Miyoshi, H. Otani, Y. Mimura, T. Ogura, and H. Makino Involvement of Bone Morphogenetic Protein-6 in Differential Regulation of Aldosterone Production by Angiotensin II and Potassium in Human Adrenocortical Cells Endocrinology, June 1, 2006; 147(6): 2681 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miyoshi, F. Otsuka, J. Suzuki, M. Takeda, K. Inagaki, Y. Kano, H. Otani, Y. Mimura, T. Ogura, and H. Makino Mutual Regulation of Follicle-Stimulating Hormone Signaling and Bone Morphogenetic Protein System in Human Granulosa Cells Biol Reprod, June 1, 2006; 74(6): 1073 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Wang, C. C. Clark, and C. T. Brighton Up-Regulation of Bone Morphogenetic Proteins in Cultured Murine Bone Cells with Use of Specific Electric Fields J. Bone Joint Surg. Am., May 1, 2006; 88(5): 1053 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mazerbourg, K. Sangkuhl, C.-W. Luo, S. Sudo, C. Klein, and A. J. W. Hsueh Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses J. Biol. Chem., September 16, 2005; 280(37): 32122 - 32132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dai, J. Keller, J. Zhang, Y. Lu, Z. Yao, and E. T. Keller Bone Morphogenetic Protein-6 Promotes Osteoblastic Prostate Cancer Bone Metastases through a Dual Mechanism Cancer Res., September 15, 2005; 65(18): 8274 - 8285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Yu, H. Beppu, N. Kawai, E. Li, and K. D. Bloch Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells J. Biol. Chem., July 1, 2005; 280(26): 24443 - 24450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Satoh, K. Kimura, Y. Okano, M. Hirakata, Y. Kawakami, and M. Kuwana Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension Rheumatology, February 1, 2005; 44(2): 192 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takeda, F. Otsuka, K. Nakamura, K. Inagaki, J. Suzuki, D. Miura, H. Fujio, H. Matsubara, H. Date, T. Ohe, et al. Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action Endocrinology, September 1, 2004; 145(9): 4344 - 4354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brederlau, R. Faigle, M. Elmi, A. Zarebski, S. Sjoberg, M. Fujii, K. Miyazono, and K. Funa The Bone Morphogenetic Protein Type Ib Receptor Is a Major Mediator of Glial Differentiation and Cell Survival in Adult Hippocampal Progenitor Cell Culture Mol. Biol. Cell, August 1, 2004; 15(8): 3863 - 3875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akiyoshi, K. Uchida, and S. Tateyama Expression of Bone Morphogenetic Protein-6 and Bone Morphogenetic Protein Receptors in Myoepithelial Cells of Canine Mammary Gland Tumors Vet. Pathol., March 1, 2004; 41(2): 154 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson The Bone Morphogenetic Protein System In Mammalian Reproduction Endocr. Rev., February 1, 2004; 25(1): 72 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Glister, C F. Kemp, and P. G Knight Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin Reproduction, February 1, 2004; 127(2): 239 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells Endocrinology, February 1, 2004; 145(2): 639 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hay, J. Lemonnier, O. Fromigue, H. Guenou, and P. J. Marie Bone Morphogenetic Protein Receptor IB Signaling Mediates Apoptosis Independently of Differentiation in Osteoblastic Cells J. Biol. Chem., January 16, 2004; 279(3): 1650 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsuyama, M. Iwadate, M. Kondo, M. Saitoh, A. Hanyu, K. Shimizu, H. Aburatani, H. K. Mishima, T. Imamura, K. Miyazono, et al. SB-431542 and Gleevec Inhibit Transforming Growth Factor-{beta}-Induced Proliferation of Human Osteosarcoma Cells Cancer Res., November 15, 2003; 63(22): 7791 - 7798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kusu, J. Laurikkala, M. Imanishi, H. Usui, M. Konishi, A. Miyake, I. Thesleff, and N. Itoh Sclerostin Is a Novel Secreted Osteoclast-derived Bone Morphogenetic Protein Antagonist with Unique Ligand Specificity J. Biol. Chem., June 20, 2003; 278(26): 24113 - 24117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tajima, K. Goto, M. Yoshida, K. Shinomiya, T. Sekimoto, Y. Yoneda, K. Miyazono, and T. Imamura Chromosomal Region Maintenance 1 (CRM1)-dependent Nuclear Export of Smad Ubiquitin Regulatory Factor 1 (Smurf1) Is Essential for Negative Regulation of Transforming Growth Factor-beta Signaling by Smad7 J. Biol. Chem., March 14, 2003; 278(12): 10716 - 10721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Moore, F. Otsuka, and S. Shimasaki Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells J. Biol. Chem., January 3, 2003; 278(1): 304 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Suzuki, G. Murakami, M. Fukuchi, T. Shimanuki, Y. Shikauchi, T. Imamura, and K. Miyazono Smurf1 Regulates the Inhibitory Activity of Smad7 by Targeting Smad7 to the Plasma Membrane J. Biol. Chem., October 11, 2002; 277(42): 39919 - 39925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Valcourt, J. Gouttenoire, A. Moustakas, D. Herbage, and F. Mallein-Gerin Functions of Transforming Growth Factor-beta Family Type I Receptors and Smad Proteins in the Hypertrophic Maturation and Osteoblastic Differentiation of Chondrocytes J. Biol. Chem., September 6, 2002; 277(37): 33545 - 33558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nishihara, T. Watabe, T. Imamura, and K. Miyazono Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary Hypertension Mol. Biol. Cell, September 1, 2002; 13(9): 3055 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Shiels, S. A. Islam, R. Vatcheva, P. Sasieni, M. J. E. Sternberg, P. S. Freemont, and D. Sheer PML bodies associate specifically with the MHC gene cluster in interphase nuclei J. Cell Sci., March 12, 2002; 114(20): 3705 - 3716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jaatinen, J. Bondestam, T. Raivio, K. Hilden, L. Dunkel, N. Groome, and O. Ritvos Activation of the Bone Morphogenetic Protein Signaling Pathway Induces Inhibin {beta}B-Subunit mRNA and Secreted Inhibin B Levels in Cultured Human Granulosa-Luteal Cells J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1254 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, C.-F. Chang, M. Morales, J. Chou, H.-L. Chen, Y.-H. Chiang, S.-Z. Lin, J. L. Cadet, X. Deng, J.-Y. Wang, et al. Bone Morphogenetic Protein-6 Reduces Ischemia-Induced Brain Damage in Rats Stroke, September 1, 2001; 32(9): 2170 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Furuhashi, K. Yagi, H. Yamamoto, Y. Furukawa, S. Shimada, Y. Nakamura, A. Kikuchi, K. Miyazono, and M. Kato Axin Facilitates Smad3 Activation in the Transforming Growth Factor {beta} Signaling Pathway Mol. Cell. Biol., August 1, 2001; 21(15): 5132 - 5141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukuchi, T. Imamura, T. Chiba, T. Ebisawa, M. Kawabata, K. Tanaka, and K. Miyazono Ligand-dependent Degradation of Smad3 by a Ubiquitin Ligase Complex of ROC1 and Associated Proteins Mol. Biol. Cell, May 1, 2001; 12(5): 1431 - 1443. [Abstract] [Full Text]
|
|
|
|
|
|
P. S. Leboy, G. Grasso-Knight, M. D'Angelo, S. W. Volk, J. B. Lian, H. Drissi, G. S. Stein, and S. L. Adams Smad-Runx Interactions During Chondrocyte Maturation J. Bone Joint Surg. Am., April 1, 2001; 83(90010): S15 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Leboy, G. Grasso-Knight, M. D'Angelo, S. W. Volk, J. B. Lian, H. Drissi, G. S. Stein, and S. L. Adams Smad-Runx Interactions During Chondrocyte Maturation J. Bone Joint Surg. Am., March 1, 2001; 83(1_suppl_1): S15 - S22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Aoki, M Fujii, T Imamura, K Yagi, K Takehara, M Kato, and K Miyazono Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction J. Cell Sci., January 4, 2001; 114(8): 1483 - 1489. [Abstract] [PDF]
|
|
|
|
|
|
T. Ebisawa, M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, T. Imamura, and K. Miyazono Smurf1 Interacts with Transforming Growth Factor-beta Type I Receptor through Smad7 and Induces Receptor Degradation J. Biol. Chem., April 13, 2001; 276(16): 12477 - 12480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gu, B.-H. Shin, Y. Akbarali, A. Weiss, J. Boltax, P. Oettgen, and T. A. Libermann Tel-2 Is a Novel Transcriptional Repressor Related to the Ets Factor Tel/ETV-6 J. Biol. Chem., March 16, 2001; 276(12): 9421 - 9436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Otsuka, R. K. Moore, and S. Shimasaki Biological Function and Cellular Mechanism of Bone Morphogenetic Protein-6 in the Ovary J. Biol. Chem., August 24, 2001; 276(35): 32889 - 32895. [Abstract] [Full Text] [PDF]
|
|
